Clinical Trial Update: PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a PD-1 inhibitor plus chemotherapy followed by immediate versus selective re-irradiation for locally advanced recurrent nasopharyngeal …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharangeal Cancer, Recurrent Nasopharynx Carcinoma | Phase 2 | Status: RECRUITING